1. Actavis May Buy Allergan for at least $60 billion - Bloomberg

    Actavis May Buy Allergan for at least $60 billion - Bloomberg

    (Reuters) - Merger talks between Allergan Inc and white knight Actavis Plc are focussed on narrowing a gap of about $3 billion (1.90 billion pounds) between what has been offered and what is wanted, Bloomberg reported on Wednesday. Actavis is willing to pay around $200 per share, or $60 billion, while Allergan wants more than $210 per share, Bloomberg said. Actavis and Allergan declined to ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned